ARTICLE | Company News
Amplimmune, American National Multiple Sclerosis Society deal
August 31, 2009 7:00 AM UTC
The society's not-for-profit technology transfer subsidiary Fast Forward LLC will provide $500,000 in funding for preclinical development of Amplimmune's AMP-110 to prevent abnormal immune responses ...